UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1‐3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.169_2631
Abstract: with eBPP at 4 UK centres. Results: From 2009, 103 patients were managed first line with either eBPP (n=51) or eBPDac (n=52) with median follow-up 37 months for eBPP and 10.4 months for eBPDac patients.… read more here.
Keywords: ebpdac patients; ebpp patients; efficacy; patients achieved ... See more keywords